ALEMBIC Fact Sheet, ALEMBIC Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC Fact Sheet    (ALMC)


Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term


Here is the latest financial fact sheet of ALEMBIC. For more details, see the ALEMBIC quarterly results and ALEMBIC share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC Price History

Price Rs 126.0
Mkt Cap Rs m 69,779
Vol '000 337.6
P/E X 74.5
P/CF X 153.1
EPS (TTM) Rs 1.7
% ch % -5.2
No. of shares m 553.80
% ch week % -2.9
% ch 1-mth % 24.3
% ch 12-mth % 162.0
52 week H/L Rs 143.3/46.0
(As on May 12, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC Financials

No. of Mths
Year Ending
12
Mar-14
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
ALEMBIC EQUITY SHARE DATA
High Rs1870534672 
Low Rs716293234 
Sales per share (Unadj.) Rs5.85.44.75.34.7 
Earnings per share (Unadj.) Rs1.14.08.85.46.1 
Diluted earnings per shareRs0.51.94.22.62.9 
Cash flow per share (Unadj.) Rs1.24.29.05.66.2 
Dividends per share (Unadj.) Rs0.150.150.150.200.20 
Adj. dividends per shareRs0.070.070.070.100.10 
Dividend yield (eoy) %1.20.30.40.50.4 
Book value per share (Unadj.) Rs8.619.827.734.140.7 
Adj. book value per shareRs4.29.513.416.519.6 
Shares outstanding (eoy) m267.03267.03267.03267.03267.03 
Bonus/Rights/Conversions  B1:1---- 
Price / Sales ratio x2.18.08.77.511.3 
Avg P/E ratio x11.210.84.77.28.7 
P/CF ratio (eoy) x10.410.24.67.08.5 
Price / Book Value ratio x1.42.21.51.21.3 
Dividend payout %13.63.81.73.73.3 
Avg Mkt Cap Rs m3,29811,46910,96210,52114,139 
No. of employees `000NANANANANA 
Total wages/salary Rs m273270238228207 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC INCOME DATA
Net Sales Rs m1,5361,4391,2601,4031,255 
Other income Rs m158208264310370 
Total revenues Rs m1,6941,6471,5241,7131,625 
Gross profit Rs m223958367111 
Depreciation Rs m2360615138 
Interest Rs m238022 
Profit before tax Rs m335235285324442 
Minority Interest Rs m00000 
Prior Period Items Rs m08252,0961,1791,212 
Extraordinary Inc (Exp) Rs m00-32-580 
Tax Rs m39-76-924 
Profit after tax Rs m2951,0662,3431,4541,630 
Gross profit margin %14.56.66.64.88.9 
Effective tax rate %11.8-2.92.1-2.65.4 
Net profit margin %19.274.1185.9103.6129.8 
ALEMBIC BALANCE SHEET DATA
Current assets Rs m1,5431,6091,6891,9131,867 
Current liabilities Rs m907533486683591 
Net working cap to sales %41.474.895.487.6101.6 
Current ratio x1.73.03.52.83.2 
Inventory Days Days24821421713294 
Debtors Days Days66122815674 
Net fixed assets Rs m1,8001,7151,6241,7161,791 
Share capital Rs m534534534534534 
"Free" reserves Rs m8743,8395,9608,58010,324 
Net worth Rs m2,3075,2787,4049,11410,858 
Long term debt Rs m3313541041841 
Total assets Rs m3,5626,1928,0109,92411,591 
Interest coverage x15.429.3950.7203.8260.9 
Debt to equity ratio x0.10.1000 
Sales to assets ratio x0.40.20.20.10.1 
Return on assets %8.917.429.314.714.1 
Return on equity %12.820.231.616.015.0 
Return on capital %13.619.031.315.815.2 
Exports to sales %7.714.32.90.71.5 
Imports to sales %3.42.528.925.421.0 
Exports (fob) Rs m118205371019 
Imports (cif) Rs m5237364356263 
Fx inflow Rs m118205371019 
Fx outflow Rs m6342365357264 
Net fx Rs m55163-328-346-244 
ALEMBIC CASH FLOW
From Operations Rs m -102 220 346 516 236 
From Investments Rs m 178 47 -48 -467 -224 
From Financial Activity Rs m -79 -250 -301 -50 -27 
Net Cashflow Rs m -3 17 -3 0 -15 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 64.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.2%
FIIs 9.7%
ADR/GDR 0.0%
Free float 26.1%
Shareholders 54,701
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, Vadodara - 390 003
E-MAIL alembic.investors@alembic.co.in WEB www.alembiclimited.com
TELEPHONE (0265) 228 0550 FAX (0265) 228 2506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, 1st Flr., Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Chirag K. Shukla YEAR OF INC: 1907 BSE CODE: 506235 FV (Rs): 2 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   J.B.CHEMICALS  GSK PHARMA  CADILA HEALTHCARE  NOVARTIS  GLENMARK PHARMA  

Compare ALEMBIC With:   J.B.CHEMICALS  GSK PHARMA  CADILA HEALTHCARE  NOVARTIS  GLENMARK PHARMA  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Views on news

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC

COMPARE ALEMBIC WITH

MARKET STATS